KRYS Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KRYS shares is 389, representing 106.84% of the company's common stock.

VERITION FUND MANAGEMENT LLC, in the last quarter, reduced its stake in KRYS by -35.6% restricting it's holding to 61.8 thousand shares of worth nearly $11.00M. RAFFERTY ASSET MANAGEMENT, LLC also lessened -36.48% of the KRYS shares from its portfolio, reducing its holding to 53.37 thousand shares of worth $9.50M. SCHRODER INVESTMENT MANAGEMENT GROUP also shunned KRYS shares holding by -47.32% last quarter which brought its holding to 39.48 thousand shares worth $7.03M.

As per its latest 13F filing, TD ASSET MANAGEMENT INC increased its stake in KRYS by 68.84% in the last quarter. The institutional holder raised its holding to 69.16 thousand shares having worth more than $12.31B. CITIGROUP INC also added 42.53% more shares of KRYS to its portfolio, raising its holding to 52.12 thousand shares of worth $9.27M. UBS GROUP AG also increased its KRYS shares holding by 65.89% which brought its holding to 51.03 thousand shares worth $9.08M.

The insider with the most stakes in KRYS is Krishnan Krish S , President and CEO at the company. Additionally, KRYS stock is highly held by President, R&D Krishnan Suma and director JANNEY DANIEL among others.

Company executives, directors, and other insiders own 12.13% percent of Krystal Biotech, Inc.'s stock. Within the last six months, there have been 4 transaction(s) in which KRYS insiders have sold stock, totaling 5.03K shares. Insiders that have sold shares include KRISHNAN SUMA, KRISHNAN KRISH S, and GANGOLLI JULIAN S.

There have been 0 transaction(s) during the past 6-months in which Krystal Biotech, Inc. insiders have bought stock, totalling 0 shares

Around 5.95M Krystal Biotech, Inc. shares are held by insiders, which represents about 12.13% of KRYS stock.

KRYS President and CEO, Krishnan Krish S holds the largest portfolio of the company's shares. KRYS shares owned by Krishnan total nearly 1.48 million.

TD ASSET MANAGEMENT INC is the largest institutional owner in KRYS which holds 69.16 thousand shares worth $12.31B or 0.25% of the total KRYS shares outstanding followed by DECHENG CAPITAL LLC with ownership of 65.77 thousand shares representing 0.24% of the KRYS ownership. VERITION FUND MANAGEMENT LLC is the third largest stakeholder with 61.8 thousand shares or 0.23% of the ownership worth more than $11.00M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KRYS is concerned, it is a stock which is optionable.

Number of KRYS shares short is 3.25M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 28.76M shares of KRYS are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KRYS has 22.93M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KRYS is 10.79.